RenovoRx: Funding, Investors & Team (Sep 2026)
RenovoRx is creating cutting-edge solutions for precise delivery of fluids, such as diagnostic and therapeutic agents, to specific areas in the peripheral vascular system. The company has received FDA approval for their RenovoCath™ RC120 and is currently introducing this advanced technology into the clinical market. RenovoRx has a dedicated Management Team with extensive experience and a promising outlook for the future of targeted delivery. The company also benefits from a diverse Advisory Board composed of interventional radiologists, surgical oncologists, and gastroenterologists who provide guidance on clinical development strategies. Supported by a committed Board of Directors, RenovoRx has the expertise and vision necessary for long-term success in the medical and biotechnology industries.
RenovoRx has raised $21.1M across 2 funding rounds on record, the most recent an undisclosed round of $10.0M announced in Mar 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
RenovoRx Company Profile and Key Stats
Latest funding round on record: Mar 2026.
RenovoRx Funding Rounds
RenovoRx raised $11.1M in an undisclosed round announced in Apr 2024.
1.9 years later, an undisclosed round of $10.0M was announced in Mar 2026.
RenovoRx Founders and Leadership Team
Contact details for the RenovoRx team: 1 has a LinkedIn profile.
Start 14-day free trial →RenovoRx Funding Compared to Other Biotechnology Startups
RenovoRx's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like RenovoRx in Biotechnology and Los Altos
Companies Similar to RenovoRx
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
RenovoRx Funding FAQs
What does RenovoRx do?
RenovoRx is creating cutting-edge solutions for precise delivery of fluids, such as diagnostic and therapeutic agents, to specific areas in the peripheral vascular system. The company has received FDA approval for their RenovoCath™ RC120 and is currently introducing this advanced technology into the clinical market. RenovoRx has a dedicated Management Team with extensive experience and a promising outlook for the future of targeted delivery. The company also benefits from a diverse Advisory Board composed of interventional radiologists, surgical oncologists, and gastroenterologists who provide guidance on clinical development strategies. Supported by a committed Board of Directors, RenovoRx has the expertise and vision necessary for long-term success in the medical and biotechnology industries.
How much funding has RenovoRx raised?
RenovoRx has raised $21.1M across 2 rounds on record. The most recent is an undisclosed round of $10.0M announced in Mar 2026.
When did RenovoRx last raise funding?
RenovoRx's most recent funding round on record is an undisclosed round of $10.0M, announced in Mar 2026.
Who founded RenovoRx?
FundedIQ lists Kamran Najmabadi (Founder), Shaun R Bagai (Founder) at RenovoRx.
Where is RenovoRx headquartered?
RenovoRx is based in Los Altos, California, United States.
How many employees does RenovoRx have?
RenovoRx is in the 11-50 employee band.
How does RenovoRx's funding compare to other Biotechnology startups?
RenovoRx's latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's RenovoRx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RenovoRx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.